These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30476149)

  • 21. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
    Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A
    Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When genetic load does not correlate with phenotypic spectrum: lessons from the GnRH receptor (GNRHR).
    Gianetti E; Hall JE; Au MG; Kaiser UB; Quinton R; Stewart JA; Metzger DL; Pitteloud N; Mericq V; Merino PM; Levitsky LL; Izatt L; Lang-Muritano M; Fujimoto VY; Dluhy RG; Chase ML; Crowley WF; Plummer L; Seminara SB
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1798-807. PubMed ID: 22745237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy.
    Peigné M; Simon V; Pigny P; Mimouni NEH; Martin C; Dewailly D; Catteau-Jonard S; Giacobini P
    Hum Reprod; 2023 May; 38(5):938-950. PubMed ID: 36921289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. At the crossroads of fertility and metabolism: the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism.
    Froment P; Plotton I; Giulivi C; Fabre S; Khoueiry R; Mourad NI; Horman S; Ramé C; Rouillon C; Grandhaye J; Bigot Y; Chevaleyre C; Le Guevel R; Mallegol P; Andriantsitohaina R; Guerif F; Tamburini J; Viollet B; Foretz M; Dupont J
    Hum Reprod; 2022 May; 37(6):1207-1228. PubMed ID: 35459945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships.
    Brioude F; Bouligand J; Trabado S; Francou B; Salenave S; Kamenicky P; Brailly-Tabard S; Chanson P; Guiochon-Mantel A; Young J
    Eur J Endocrinol; 2010 May; 162(5):835-51. PubMed ID: 20207726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel GNRHR gene mutation causing congenital hypogonadotrophic hypogonadism in a Brazilian kindred.
    Correa-Silva SR; Fausto JDS; Kizys MML; Filipelli R; Marco Antonio DS; Oku AY; Furuzawa GK; Orchard EVH; Costa-Barbosa FA; Mitne-Neto M; Dias-da-Silva MR
    J Neuroendocrinol; 2018 Dec; 30(12):e12658. PubMed ID: 30415482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ovary syndrome as potential diagnostic markers.
    Insenser M; Quintero A; de Lope S; Álvarez-Blasco F; Martínez-García MÁ; Luque-Ramírez M; Escobar-Morreale HF
    Hum Reprod; 2023 May; 38(5):951-960. PubMed ID: 36931262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA; Lee P; Smith HC
    Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted inhibition of kisspeptin neurons reverses hyperandrogenemia and abnormal hyperactive LH secretion in a preclinical mouse model of polycystic ovary syndrome.
    Coutinho EA; Esparza LA; Rodriguez J; Yang J; Schafer D; Kauffman AS
    Hum Reprod; 2024 Sep; 39(9):2089-2103. PubMed ID: 38978296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
    Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
    Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline.
    Kim JJ; Hwang KR; Lee D; Kim S; Choi YM
    Hum Reprod; 2024 May; 39(5):1072-1077. PubMed ID: 38514450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations.
    Huang CC; Tien YJ; Chen MJ; Chen CH; Ho HN; Yang YS
    Hum Reprod; 2015 Apr; 30(4):937-46. PubMed ID: 25662806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966.
    West S; Vähäsarja M; Bloigu A; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Corbett S; Vääräsmäki M; Morin-Papunen L
    Hum Reprod; 2014 Mar; 29(3):628-33. PubMed ID: 24324025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea.
    Carmina E; Fruzzetti F; Lobo RA
    Am J Obstet Gynecol; 2016 Jun; 214(6):714.e1-6. PubMed ID: 26767792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.